Related Experiment Video
Updated: May 27, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Guanine triphosphate-cyclohydrolase 1-deficient dopa-responsive dystonia presenting as frequent falling in 2 children
1Department of Pediatrics and Neurology, The Ohio State University, Columbus, OH 43205, USA. changyong.tsao@nationwidechildrens.org
Insights
Guanine triphosphate (GTP)-cyclohydrolase 1 (GCH1) deficiency, caused by GCH1 gene mutations, leads to dopa-responsive dystonia. Children with this condition show persistent improvement with low-dose levodopa/carbidopa treatment.
Area of Science:
- Genetics
- Neurology
- Biochemistry
Background:
- Dopa-responsive dystonia (DRD) is a rare inherited neurological disorder.
- Mutations in the Guanine triphosphate (GTP)-cyclohydrolase 1 (GCH1) gene are a known cause of DRD.
- GCH1 encodes the rate-limiting enzyme in tetrahydrobiopterin (BH4) biosynthesis, essential for neurotransmitter synthesis.
Observation:
- Two children presented with frequent daily falls, a significant mobility impairment.
- Clinical evaluation revealed GCH1 gene mutations in both affected children.
- Both patients exhibited a persistent positive response to low-dose levodopa/carbidopa therapy.
Findings:
- The study confirms GCH1 gene mutations as the cause of DRD in these pediatric patients.
- Persistent therapeutic response to levodopa/carbidopa was observed even at low dosages.
- Review of typical and atypical clinical features associated with GCH1 mutations was conducted.
Implications:
- Early diagnosis and treatment of GCH1-deficient DRD can significantly improve patient mobility and quality of life.
- Low-dose levodopa/carbidopa represents an effective and accessible therapeutic strategy.
- Understanding the clinical spectrum of GCH1 mutations aids in diagnosing both classic and atypical presentations.
Abstract:
Guanine triphosphate (GTP)-cyclohydrolase 1 (GCH1)-deficient dopa-responsive dystonia is caused by GCH1 gene mutation. Two children presenting with frequent daily falling are reported with GCH1 gene mutations with persistent response to low-dose levodopa/carbidopa. Typical and atypical clinical features associated with GCH1 mutations are also reviewed.
Related Concept Videos
Huntington Disease l: Introduction
Alterations in Muscle Tone ll
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Inborn Errors of Metabolism
Alterations in Muscle Tone lll

